Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Aurora Cannabis Inc.NASDAQ: ACB

Net Receivables · Q4 FY2026 · quarter ended Mar 2026

Net receivables rises 5.8% from a year ago

Net receivables stood at CA$44.69M at the end of Q4 FY2026, up 5.8% from a year earlier and up 1.1% from the prior quarter. Over 3 fiscal years it compounded at +2.6% a year.

Context

  • Net receivables amounted to 7.4% of total assets at the end of Q4 FY2026, up 2.4 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +5.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$44.69M+1.1% QoQ
Last fiscal yearMar 2026
CA$44.69M+5.8% YoY
Year agoMar 2025
CA$42.23M+5.8% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.8%——
1 year+5.8%——
3-year CAGR+2.6%——
5-year CAGR——
10-year CAGR——

Net Receivables history

CAD · from the balance sheet

Latest · FY2026
44.69M CAD
Year-over-year change
+5.8%
4-year CAGR
+2.0%

Net Receivables vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +5.8% is the 7th highest of 10, against a peer median of +96.4%.
  • Net receivables amounts to 7.4% of total assets for ACB, versus a peer median of 4.5%.
ACB Competitors
Net Receivables for ACB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IRWDIronwood Pharmaceuticals, Inc.Mar 2026$105.84M USD+166.1%-26.0%24.4%
OGIOrganigram Global Inc.Mar 2026CA$53.53M CAD+14.3%—10.2%
ACBAurora Cannabis Inc.Mar 2026CA$44.69M CAD+5.8%+2.6%7.4%
CGCCanopy Growth CorporationMar 2026CA$36.29M CAD-31.2%-19.1%3.2%
LFCRLifecore Biomedical, Inc.Dec 2025$33.82M USD——14.6%
LFMDLifeMD, Inc.Mar 2026$9.86M USD-3.3%+48.6%14.1%
HITIHigh Tide Inc.Apr 2026CA$7.72M CAD+180.5%-10.8%2.2%
TKNOAlpha Teknova, Inc.Mar 2026$5.67M USD+1.0%+2.5%5.7%
ACRSAclaris Therapeutics, Inc.Mar 2026$4.81M USD+1825.6%+125.7%2.4%
EDITEditas Medicine, Inc.Mar 2026$2.59M USD+408.2%+43.4%1.7%
BIOABioAge Labs, Inc.Mar 2026$709K USD+96.4%—0.2%
Peer median (excluding ACB) —+96.4%+2.5%4.5%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Cash & Equivalents300.86M300.86M179.53M184.26M112.77M
Short-term Investments004.04M550.82K52.35M
Net Receivables41.35M41.35M45.49M42.23M44.69M
Inventory128.83M128.83M186.7M237.72M175.53M
Other Current Assets8.92M8.92M11.58M10.82M13.14M
Total Current Assets479.96M479.96M427.35M475.58M398.48M
Property, Plant & Equipment (Net)322.99M322.99M294.84M266.57M124.01M
Goodwill18.72M18.72M43.26M43.62M26.72M
Intangible Assets59.68M59.68M40.92M44.9M31.52M
Long-term Investments13.75M13.75M6.35M5.23M15.82M
Tax Assets15.5M15.5M15.37M4.19M2.46M
Other Non-current Assets15.79M15.79M12.05M7.68M3.63M
Total Non-current Assets446.42M446.42M412.79M372.19M204.16M
Total Assets926.38M926.38M840.14M847.77M602.64M
Account Payables21.94M21.94M20.36M27.46M9.33M
Short-term Debt147.56M147.56M57.32M26.74M5.74M
Tax Payables1.13M161K4.05M10.11M0
Deferred Revenue1.74M1.74M1.69M1.07M1.27M
Other Current Liabilities53.73M53.73M28.4M27.87M30.12M
Total Current Liabilities237.75M237.75M124.84M110.23M67.1M
Long-term Debt36.17M36.17M4.91M39.96M0
Deferred Tax Liabilities16.75M16.75M16.22M1.89M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities71.3M71.3M53.69M53.32M4.21M
Total Non-current Liabilities166.89M166.89M112.38M132.45M22.38M
Total Liabilities404.64M404.64M237.22M242.67M89.49M
Common Stock6.84B6.84B6.98B6.95B7.03B
Retained Earnings(6.29B)(6.29B)(6.38B)(6.33B)(6.46B)
Accumulated OCI(58.33M)(58.33M)(43.78M)(55.91M)(214.15M)
Other Stockholders Equity00000
Minority Interest31.06M31.06M42.17M41.18M0
Total Equity521.74M521.74M602.92M605.09M513.15M
Total Debt226.41M226.41M99.78M103.98M23.92M
Net Debt(74.45M)(74.45M)(79.75M)(80.28M)(88.85M)

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.